TrialObstetrics and gynecology2018

Elagolix Alone or With Add-Back Therapy in Women With Heavy Menstrual Bleeding and Uterine Leiomyomas: A Randomized Controlled Trial.

Bruce R Carr et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.